Gender Analysis of Moxifloxacin Clinical TrialsCHILET-ROSELL, Elisa; RUIZ-CANTERO, Ma Teresa; PARDO, Ma Angeles et al.Journal of women's health (Larchmont, N.Y. 2002). 2014, Vol 23, Num 1, pp 77-104, issn 1540-9996, 28 p.Article

Biological assay and liquid chromatographic method for analysis of moxifloxacin in tabletsGUERRA, Fanny L. B; PAIM, Clesio S; STEPPE, Martin et al.Journal of AOAC International. 2005, Vol 88, Num 4, pp 1086-1092, issn 1060-3271, 7 p.Article

Penetration of Moxifloxacin into Bone Evaluated by Monte Carlo SimulationLANDERSDORFER, Cornelia B; KINZIG, Martina; HENNIG, Friedrich F et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 5, pp 2074-2081, issn 0066-4804, 8 p.Article

The Effect of Moxifloxacin on QTc and Implications for the Design of Thorough QT StudiesBLOOMFIELD, D. M; KOST, J. T; GHOSH, K et al.Clinical pharmacology and therapeutics. 2008, Vol 84, Num 4, pp 475-480, issn 0009-9236, 6 p.Article

Protonation equilibrium and lipophilicity of moxifloxacinLANGLOIS, Marie-Hélène; MONTAGUT, Martine; DUBOST, Jean-Pierre et al.Journal of pharmaceutical and biomedical analysis. 2005, Vol 37, Num 2, pp 389-393, issn 0731-7085, 5 p.Article

Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive TuberculosisGILLESPIE, Stephen H; CROOK, Angela M; McHUGH, Timothy D et al.The New England journal of medicine. 2014, Vol 371, Num 17, pp 1577-1587, issn 0028-4793, 11 p.Article

Penetration of moxifloxacin into the human aqueous humour after oral administrationKAMPOUGERIS, G; ANTONIADOU, A; KAVOUKLIS, E et al.British journal of ophthalmology. 2005, Vol 89, Num 5, pp 628-631, issn 0007-1161, 4 p.Article

In vitro activity of moxifloxacin against 923 anaerobes isolated from human intra-abdominal infectionsGOLDSTEIN, Ellie J. C; CITRON, Diane M; WARREN, Yumi A et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 1, pp 148-155, issn 0066-4804, 8 p.Article

Structural identification and characterization of impurities in moxifloxacinRAVINDRA KUMAR, Y; PRASAD RAJU, V. V. N. K. V; RAJESH KUMAR, R et al.Journal of pharmaceutical and biomedical analysis. 2004, Vol 34, Num 5, pp 1125-1129, issn 0731-7085, 5 p.Article

Detection of resistance to gatifloxacin and moxifloxacin in Streptococcus pneumoniae with the VITEK 2 instrumentJORGENSEN, J. H; CRAWFORD, S. A; MCELMEEL, L. M et al.Journal of clinical microbiology (Print). 2004, Vol 42, Num 12, pp 5928-5930, issn 0095-1137, 3 p.Article

Enantiomeric purity assay of moxifloxacin hydrochloride by capillary electrophoresisCRUZ, Lou Ann; HALL, Rex.Journal of pharmaceutical and biomedical analysis. 2005, Vol 38, Num 1, pp 8-13, issn 0731-7085, 6 p.Article

Moxifloxacin Retains Antimycobacterial Activity in the Presence of gyrA MutationsMCGRATH, Marieta; VAN PITTIUS, Nico C. Gey; SIRGEL, Frederick A et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 5, pp 2912-2915, issn 0066-4804, 4 p.Article

Determination of Moxifloxacin and its Oxidation Products with Kinetic Evaluation Under Potassium Permanganate Treatment in Acidic Solution by Ultra-Performance Liquid Chromatography/Tandem Mass SpectrometryHUBICKA, Urszula; ZMUDZKI, Paweł; ZAJDEL, Paweł et al.Journal of AOAC International. 2013, Vol 96, Num 6, pp 1288-1294, issn 1060-3271, 7 p.Article

Moxifloxacin Punctum Plug for Sustained Drug DeliveryCHEE, Soon-Phaik.Journal of ocular pharmacology and therapeutics. 2012, Vol 28, Num 4, pp 340-349, issn 1080-7683, 10 p.Article

Mutant prevention concentrations of ABT-492, levofloxacin, moxifloxacin, and gatifloxacin against three common respiratory pathogensHERMSEN, Elizabeth D; HOVDE, Laurie B; KONSTANTINIDES, George N et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 4, pp 1633-1635, issn 0066-4804, 3 p.Article

Changing patterns of fluoroquinolone resistance among Bacteroides fragilis group organisms over a 6-year period (1997-2002)BETRIU, Carmen; RODRIGUEZ-AVIAL, Iciar; GOMEZ, Maria et al.Diagnostic microbiology and infectious disease. 2005, Vol 53, Num 3, pp 221-223, issn 0732-8893, 3 p.Article

Influence of efflux transporters on the accumulation and efflux of four quinolones (ciprofloxacin, levofloxacin, garenoxacin, and moxifloxacin) in J774 macrophagesMICHOT, Jean-Michel; SERAL, Cristina; VAN BAMBEKE, Francoise et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 6, pp 2429-2437, issn 0066-4804, 9 p.Article

Moxifloxacin penetration into human gastrointestinal tissuesWIRTZ, Martin; KLEEFF, Jörg; SWOBODA, Stefanie et al.Journal of antimicrobial chemotherapy (Print). 2004, Vol 53, Num 5, pp 875-877, issn 0305-7453, 3 p.Article

Pharmacokinetics of moxifloxacin in patients undergoing continuous venovenous haemodiafiltrationFUHRMANN, Valentin; SCHENK, Peter; JAEGER, Walter et al.Journal of antimicrobial chemotherapy (Print). 2004, Vol 54, Num 4, pp 780-784, issn 0305-7453, 5 p.Article

Antibacterial activity of moxifloxacin on bacteria associated with periodontitis within a biofilmTSAOUSOGLOU, Phoebus; NIETZSCHE, Sandor; CACHOVAN, Georg et al.Journal of medical microbiology. 2014, Vol 63, Num 2, pp 284-292, issn 0022-2615, 9 p.Article

Activity of moxifloxacin against Bacteroides fragilis and Escherichia coli in an in vitro pharmacokinetic/ pharmacodynamic model employing pure and mixed culturesSCHAUMANN, Reiner; GOLDSTEIN, Ellie J. C; FORBERG, Jochen et al.Journal of medical microbiology. 2005, Vol 54, Num 8, pp 749-753, issn 0022-2615, 5 p.Article

Pharmacodynamics of moxifloxacin against anaerobes studied in an in vitro pharmacokinetic modelNOEL, Alan R; BOWKER, Karen E; MACGOWAN, Alasdair P et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 10, pp 4234-4239, issn 0066-4804, 6 p.Article

In vitro activity of moxifloxacin against community respiratory pathogens in QatarSITTANA SHAMSELDIN ELSHAFIE; AL-KUWARI, Jameela.International journal of antimicrobial agents. 2004, Vol 24, Num 3, pp 309-310, issn 0924-8579, 2 p.Article

Biopharmaceutical Characterization of Nebulized Antimicrobial Agents in Rats: 1. Ciprofloxacin, Moxifloxacin, and GrepafloxacinLACERDA GONTIJO, Aline Vidal; BRILLAULT, Julien; GREGOIRE, Nicolas et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 7, pp 3942-3949, issn 0066-4804, 8 p.Article

Moxifloxacin in lower respiratory tract infections: in silico simulation of different bacterial resistance and drug exposure scenariosSALEM, Ahmed H; NOREDDIN, Ayman M.Journal of chemotherapy (Testo stampato). 2014, Vol 26, Num 2, pp 80-85, issn 1120-009X, 6 p.Article